✦ LIBER ✦

Treatment of recurrent or persistent platinum-refractory ovarian, fallopian tube or primary peritoneal cancer with gemcitabine and topotecan: A phase II trial of the Puget Sound Oncology Consortium

✍ Scribed by Barbara A. Goff; Leona A. Holmberg; Dan Veljovich; Brenda F. Kurland

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of recurrent platinum resistan

✍ Barbara A. Goff; Tove Thompson; Benjamin E. Greer; Andrew Jacobs; Barry Storer 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Phase II evaluation of topotecan and nav

✍ Thomas J. Herzog; Matthew A. Powell; Janet S. Rader; Randall K. Gibb; Lynne Lipp 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 424 KB

Phase II study of bevacizumab and pemetr

✍ Hagemann, Andrea R.; Novetsky, Akiva P.; Zighelboim, Israel; Gao, Feng; Massad, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 264 KB

A Phase II trial of oral capecitabine in

✍ Judith K. Wolf; Diane C. Bodurka; Claire Verschraegen; Charlotte C. Sun; Donna B 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 167 KB

A phase II evaluation of belinostat and

✍ Don S. Dizon; John A. Blessing; Richard T. Penson; Richard D. Drake; Joan L. Wal 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 197 KB

A phase II evaluation of nanoparticle, a

✍ Robert L. Coleman; William E. Brady; D. Scott McMeekin; Peter G. Rose; John T. S 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 214 KB